MXC.AX - MGC Pharmaceuticals Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2019
30/06/2018
30/06/2017
30/06/2016
Total revenue
553
656
297
120
2
Cost of revenue
168
357
119
158
15
Gross profit
385
300
177
-38
-15
Operating expenses
Research development
1,608
2,866
951
-
-
Selling general and administrative
3,429
3,423
3,973
4,472
923
Total operating expenses
7,923
9,339
7,438
7,282
4,363
Operating income or loss
-7,538
-9,039
-7,261
-7,320
-4,378
Interest expense
166
8
99
20
120
Total other income/expenses net
6,536
6,969
-1,822
-1,290
-1,734
Income before tax
-844
-1,876
-8,990
-8,502
-6,230
Income tax expense
-1
27
-1
0
0
Income from continuing operations
-843
-1,904
-8,989
-8,502
-6,230
Net income
-600
-2,309
-8,246
-8,144
-6,157
Net income available to common shareholders
-600
-2,309
-8,246
-8,144
-6,157
Reported EPS
Basic
-
-
-0.01
-0.01
-0.01
Diluted
-
-
-0.01
-0.01
-0.01
Weighted average shares outstanding
Basic
-
-
1,125,543
966,344
603,563
Diluted
-
-
1,125,543
966,344
603,563
EBITDA
-
-1,609
-8,563
-8,399
-6,093